Poster CASE - Heart Failure/Transplantation

1326 - Methotrexate as a Rescue Therapy for Persistent Cellular Rejection and Donor Specific Antibody Reduction

Presentation Number
1326
Presenter
Session Name
PO-1-CASE - Poster Session 1: Junior Faculty Clinical Case Reports
Date
Wed, Apr 11, 2018
Time
06:15 PM - 07:15 PM
Co-Authors

Previous Eposter
1064 - Baseline and 1-year Follow-up Serial Optical Coherence Tomography Evaluation of Coronary Plaques in Heart Transplant Recipients

Next Eposters
1305 - Cardiac Transplantation for Ventricular Tachycardia Storm Due to Cardiac Hemangioma
1052 - Is Low-rpm a Risk Factor for Pump Thrombosis in Pediatric Patients with HeartWare HVAD?
1337 - Time to Relapse: Infection in Destination LVAD Recipients
1099 - Novel Technique to Reduce Warm Ischemic Time During Cardiac Implantation
1224 - Spousal Support Does Not Affect Outcomes in Patients with Continuous Flow Left Ventricular Assist Device
610 - A Donor PO2/FiO2 Less Than 300 Does Not Determine Graft Function or Survival After Lung Transplantation
894 - Is Depression After Heart Transplantation (HTx) Associated With Impaired Survival During Long-term Follow-up?
903 - The Effect of Dual Renin-angiotensin System Blockade Compared to Conventional Antihypertensive Combination on Blood Pressure and Renal Function After Heart Transplantation: A Randomized Controlled Trial
1074 - The Effect of Everolimus vs Calcineurin Inhibitors on Left Ventricular Mass in De Novo Heart Transplant Recipients After 3 Years Follow-Up - Results From the Randomized Controlled SCHEDULE Trial
832 - Recipient Age and Acute Cellular Rejection - Implications for Targeted Surveillance After Heart Transplantation